Infectious disease diagnostics moved from a quiet corner of the lab to the center of public attention almost overnight — and the hiring market never fully settled back down.
Companies building syndromic panels, point-of-care molecular tests, sequencing-based pathogen ID, and antimicrobial resistance assays are all competing for the same relatively small pool of people who genuinely understand this space.
If you have tried to fill a commercial or regulatory role here with a generalist recruiter, you already know the problem: the résumés look right on paper and fall apart in the first technical screen.
This is a guide for employers — hiring managers, lab directors, commercial leaders, and founders — on how to think about hiring in infectious disease diagnostics: which roles are hardest to fill, what is driving demand, and how to evaluate candidates whose experience actually translates.
It also explains why working with infectious disease executive recruiters who know the segment tends to shorten a search that would otherwise stall.
"Diagnostics" is not one talent market — it is several that don't cross over cleanly.
Someone who has spent a career selling oncology NGS panels into academic medical centers is not automatically equipped to sell a respiratory PCR panel into a hospital microbiology lab. A regulatory specialist who has run oncology companion diagnostic submissions may have never touched an infectious disease 510(k). The clinical workflow, the buyer, the reimbursement picture, and the regulatory framework are all different.
Infectious disease adds its own wrinkles on top of that. Demand is episodic and outbreak-driven, so commercial forecasting and inventory planning look different than in stable testing categories.
Assays often have to detect multiple pathogens at once, which raises the technical bar for both R&D and the field scientists who support the product. And the regulatory environment spans FDA-cleared IVDs, laboratory-developed tests, and Emergency Use Authorization pathways that most candidates outside the space have never worked within.
An infectious disease executive search firm that recruits here regularly screens for exactly these distinctions rather than discovering them mid-interview.
Across infectious disease diagnostics companies, a handful of roles consistently create the most hiring pain.
Selling infectious disease diagnostics requires scientific credibility alongside commercial skill.
A territory rep or clinical sales specialist has to hold a real conversation with a microbiology lab director about assay sensitivity, turnaround time, and how a panel fits an existing testing algorithm — not just position against a competitor on price.
VP of Sales and Chief Commercial Officer searches are harder still, because the right leader has usually built a commercial function in a regulated diagnostics environment before, not simply inherited one.
Field Application Scientists (FAS), applications specialists, and clinical educators sit between pure science and pure sales, and they are perennially hard to find.
In infectious disease, the FAS needs genuine familiarity with the assay chemistry — PCR methodology, multiplex panel design, or sequencing workflows — plus the customer's lab workflow. This is the role most likely to make or break a product launch, and the one where a specialist network pays off most.
The difference between a 510(k) path, a De Novo, a PMA, and an LDT matters enormously when you are evaluating a regulatory candidate, and infectious disease submissions carry their own history around EUAs and rapidly evolving FDA thinking.
Regulatory Affairs Directors, Clinical Affairs leaders, and QA professionals fluent in ISO 13485 and 21 CFR Part 820 are a consistently thin market — and a bad hire here delays your submission, not just your org chart.
Assay development scientists with hands-on qPCR, multiplex, or NGS experience specific to pathogen detection are in demand from both established manufacturers and venture-backed startups.
Bioinformatics and pathogen-genomics talent has become part of this same competition as sequencing-based infectious disease testing scales.
Several forces keep this hiring market tight.
Syndromic panel testing — running one sample against many possible pathogens — continues to expand from large reference labs toward point-of-care and near-patient settings, which pulls in commercial and field talent who can sell and support decentralized platforms.
Antimicrobial resistance has become a durable clinical and regulatory priority, driving new assay development and the scientific hiring that comes with it. Pandemic preparedness funding and next-generation sequencing for pathogen surveillance have created roles that barely existed a few years ago.
And the overall shift toward molecular methods means companies increasingly want candidates who combine infectious disease domain knowledge with molecular fluency — a narrower pool than either skill set alone.
A few practical screens separate strong infectious disease diagnostics candidates from people whose experience only looks adjacent.
Start with the buyer. Ask commercial candidates to walk you through who they actually sold to and how that lab made purchasing decisions — a microbiology lab, an infection-control committee, and a hospital value-analysis team buy very differently, and a rep who has genuinely navigated those dynamics will describe them in specifics.
Probe the assay depth. For FAS and scientific roles, have them explain a multiplex panel they supported, the failure modes they troubleshot, and how they trained a customer through a go-live.
Get specific on regulatory. For regulatory candidates, pin down submission type and pathogen category — "regulatory experience" is not interchangeable, and the person who led an infectious disease 510(k) is not the same hire as someone who has only worked in a different diagnostics vertical.
Finally, weigh adaptability heavily for early-stage and outbreak-exposed companies. The strongest infectious disease candidates are usually comfortable operating where the technology, the market, and sometimes the regulatory pathway are still being defined. Pedigree matters less than a demonstrated ability to build and adjust.
The reason generalist firms struggle in this space is simple: they cannot tell, from a résumé, which experience translates and which only looks like it does.
A specialist firm maintains a live network of the relatively small number of people who have actually done these jobs, and screens for the scientific, regulatory, and commercial nuances before a candidate ever reaches your desk. That is the difference between a search that fills and one that circles for months.
Connexis has recruited exclusively in diagnostics, life sciences, and medical device since 2001, and several of our recruiters came out of the industry before they recruited for it.
Our molecular diagnostics recruiting practice covers infectious disease across commercial, scientific, regulatory, and technical roles, and it sits alongside our broader diagnostics recruiting practice.
Have an infectious disease diagnostics search that's stalled?
Whether you need a commercial leader, a Field Application Scientist, a regulatory specialist, or a senior assay development scientist — tell us what you're looking for, and we'll tell you honestly whether it's a search we can move quickly.
Submit a Search or Schedule a Call →